Abstract
Siemens Healthcare is one of the world' s largest suppliers to the healthcare
industry. The company has long been renowned for its medical imaging systems,
including X-ray, computed tomography (CT), magnetic resonance imaging (MRI),
positron emission tomography (PET), mammography, angiography, ultrasound and
molecular imaging (MI) products, as well as related computer-based
workstations, healthcare IT systems, oncology care products and hearing aids.
Siemens is also an investor in Drager Medical, a leading player in the market
for electromedical systems, including patient monitoring products and
electrophysiological measuring systems.
In recent years, Siemens has been expanding its medical portfolio through
targeted acquisitions. By acquiring Shared Medical Systems (healthcare IT) in
2000, CTI Molecular Imaging in 2005, Diagnostic Products Corporation (DPC) and
Bayer Diagnostics in 2006, and Dade Behring in 2007, Siemens effectively
created the world' s first and fully-integrated diagnostics company, combining
imaging diagnostics, laboratory diagnostics and clinical IT under one roof. As
a result, Siemens Healthcare now delivers solutions across the entire
continuum of care - from prevention and early detection, to diagnosis,
therapy and care.
The acquisition strategy is paying dividends by doubling the overall market
served by Siemens' Healthcare sector to EUR57 billion and giving the group
access to further attractive market segments. At the time of writing, Siemens'
Healthcare sector' s target margin range remained at 14 to 17%, despite the
continued negative pressures wrought by the global economic recession.
The company employs more than 49,000 people worldwide and operates in 130
countries. In fiscal 2008 (year to 30th September 2008), Siemens Healthcare
reported sales of EUR11.170 billion (14.4% of group consolidated revenues for
the year) and profit of EUR1.225 billion.
This company report provides
Overview
- Key contact information
- Introduction to the company and its current activities
- Summary of its financial performance
- Who are the company' s major competitors?
- Key recent events in an “at a glance” format
Financial Review
- Current year and annual financial data, including revenue breakdowns by
product area and geographic region (if available)
- Table providing in-depth five-year financial analysis
- Employee data, including breakdown by company division and geographic
location
Strategic Focus
Investigates the company' s aims and its areas of focus
Products
Core product areas, key brands, product approvals and launches
Research and Development
- How much has been invested in R&D?
- Where is the research based?
- What alliances and agreements does the company have and with whom?
Manufacturing and Distribution
- Identifying the company' s manufacturing locations
- Sales and marketing facilities
Agreements
- With whom has the company reached agreements and what do they involve?
- Key contracts awarded
Mergers, Acquisitions, Minority Investments and Joint Ventures
Divestments
Litigation
Key Corporate Events
| 
View Cart
